Even George Soros’ billions can’t help him out of the latest bind he’s in with his home country’s nationalistic government.
Just today, the Hungarian parliament passed a new law that could force George Soros-funded Central European University (CEU) to close its doors after 26 years.
Image Caption: George Soros speaking in Munich, March 20, 2014.
CEU was financed and built by Soros in 1991 in the wake of Hungary’s Communist collapse.
Thousands of students, professors, and supporters have rallied in recent days to keep the university open. They cite its historical relevance to the country’s history as one good reason.
These protestors likewise demanded the Hungarian government withdraw the draft legislation set to be voted on today.
Top 5 Heal Care Stocks To Invest In Right Now: EPR Properties(EPR)
- [By Laurie Kulikowski]
EPR’s revenue growth has slightly outpaced the industry average of 6.1%. Since the same quarter one year prior, revenues slightly increased by 9.7%. This growth in revenue appears to have trickled down to the company’s bottom line, improving the earnings per share.
- [By Laurie Kulikowski]
The company, on the basis of net income growth from the same quarter one year ago, has significantly outperformed against the S&P 500 and exceeded that of the Real Estate Investment Trusts (REITs) industry average. The net income increased by 17.5% when compared to the same quarter one year prior, going from $42.71 million to $50.20 million.
- [By Laurie Kulikowski]
Net operating cash flow has increased to $64.42 million or 19.61% when compared to the same quarter last year. The firm also exceeded the industry average cash flow growth rate of 9.39%.
The gross profit margin for EPR PROPERTIES is currently very high, coming in at 73.12%. Regardless of EPR’s high profit margin, it has managed to decrease from the same period last year. Despite the mixed results of the gross profit margin, EPR’s net profit margin of 46.18% significantly outperformed against the industry.
- [By Laurie Kulikowski]
EPR’s investment pipeline should drive about 6-7% earnings growth in 2016, and historically the company’s dividend growth has roughly equated to earnings growth. Starting with an above-average 6.5% yield, we find this compelling for income-oriented investors.
Top 5 Heal Care Stocks To Invest In Right Now: Jazz Pharmaceuticals Inc.(JAZZ)
- [By Teresa Rivas]
Jazz Pharmaceuticals (JAZZ) is trading up nearly 9% Thursday, thanks to its settlement with Hikma Pharmaceuticals over the firms patent dispute.
As part of the agreement, Hikma will get to sell a generic version of the drug in question, narcolepsy treatment Xyrem, in 2023, for up to five years, while Jazz will get royalties on those sales.
Janney Montgomery Scotts Ken Trbovich upgraded the shares from Neutral to Buy on the news, and also increased his price target from $138 to $175. From his note:
While this comes about three years earlier than previous settlements with other generic filers, it eliminates the risk of an earlier launch. Six months thereafter Hikma may launch its own generic and others may potentially be able to launch as well. Importantly, Jazz will receive a meaningful royalty on sales, retain the right to launch its own AG, and can authorize other AGs after the initial 6-month Hikma period.
Jazz shares are up 8.9% to $153.2o at recent check.
- [By Jim Robertson]
The earnings report summarized the following recent milestones:
The formation of a Scientific Advisory Board (SAB) to provide expert guidance and insight as the Company advances towards product commercialization. in October, Pfenex announced the hiring of Steven Sandoval as Chief Manufacturing Officer.Steven has over 25 years of commercial biopharmaceutical engineering and operations experience, specializing in commercial operations, facility design and licensure of large scale biopharmaceutical commercial manufacturing facilities. Following the announcement in August of the positive Phase 1 trial data for Pfenex’s recombinant anthrax vaccine, discussions with BARDA have been progressing. Pfenex anticipates initiating the PF708 pivotal clinical program by year end. Pfenex entered into a collaboration with Jazz Pharmaceuticals plc (NASDAQ: JAZZ) on multiple hematology/oncology product candidates in July. Regulatory feedback for PF529, Pfenex’s biosimilar candidate to Neulasta (pegfilgrastim), is expected by the end of 2016 and following that feedback, the development path and potential timeline will be outlined.
Do you like this trading idea and want more trading setups delivered to you every day? Consider investing in a subscription to our SmallCap Network Elite Opportunity (SCN EO) portfolio newsletter or our Under the Radar Movers newsletter where you’ll get more and even better trading setups, investing ideas or tips.
- [By Keith Speights]
In December, I included Jazz Pharmaceuticals (NASDAQ:JAZZ) in a list of the three top healthcare stocks investors were overlooking. At that time, I noted that the biotech stock could be a diamond in the rough with its promising pipeline and low valuation.
- [By Benzinga News Desk]
On Wednesday, just 24 hours after Amazon announced its first major sports deal — tying up with the NFL to stream 10 Thursday night games — Alphabet Inc (NASDAQ: GOOGL) laid claim to viewers’ credit cards by debuting YouTube TV, a bundle of 50 major television channels for $35 per month: Link
ECONOMIC DATA March 2017 US Challenger layoffs report 43,310 vs 36,975 Initial Jobless Claims for Mar 31 234.0K vs 250.0K estimate; Continuing Claims for Mar 24 2.03M vs 2.04M estimate. San Francisco Federal Reserve Bank President John Williams is set to speak in Frankfurt at 9:30 a.m. ET. The Energy Information Administration’s weekly report on natural gas stocks is schedule for release at 10:30 a.m. ET. Data on money supply for the recent week will be released at 4:30 p.m. ET. ANALYST RATINGS Goldman Sachs initiated Advanced Micro Devices (NASDAQ: AMD) at Sell JMP Securities upgraded NetApp (NASDAQ: NTAP) from Market Underperform to Market Perform PiperJaffray upgraded Abiomed (NASDAQ: ABMD) from Neutral to Overweight Deutsche Bank downgraded T-Mobile (NASDAQ: TMUS) from Buy to Hold Mizuho downgraded Jazz Pharmaceuticals (NASDAQ: JAZZ) from Buy to Neutral
This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here or email firstname.lastname@example.org.
- [By Lisa Levin] Gainers Trevena Inc (NASDAQ: TRVN) rose 10.8 percent to $3.60 in pre-market trading after dropping 4.97 percent on Wednesday. Yum China Holdings Inc (NYSE: YUMC) rose 10.2 percent to $31.05 in pre-market trading after the company reported upbeat earnings for its first quarter. Seres Therapeutics Inc (NASDAQ: MCRB) rose 9.1 percent to $11.39 in pre-market trading after dropping 5.26 percent on Wednesday. Plug Power Inc (NASDAQ: PLUG) rose 8.9 percent to $2.45 in pre-market trading after surging 73.08 percent on Wednesday. Coach Inc (NYSE: COH) rose 6.7 percent to $41.98 in pre-market trading. Coach named Ian Bickley as President, Global Business Development and Strategic Alliances. Sapiens International Corporation N.V. (NASDAQ: SPNS) shares rose 6.1 percent to $13.91 in pre-market trading after gaining 0.54 percent on Wednesday. Jazz Pharmaceuticals plc (NASDAQ: JAZZ) rose 6.1 percent to $149.15 in pre-market trading. Jazz Pharma reached a settlement with Hikma Pharma related to Xyrem patent case. Mizuho downgraded Jazz from Buy to Neutral. Interactive Brokers Group, Inc. (NASDAQ: IBKR) shares rose 6 percent to $36.72 in pre-market trading after declining 0.03 percent on Wednesday. Rewalk Robotics Ltd (NASDAQ: RWLK) rose 5.3 percent to $2.00 in pre-market trading after the company disclosed that the U.S. Department of Veterans Affairs purchased 28 added Exoskeleton Systems. Merrimack Pharmaceuticals Inc (NASDAQ: MACK) rose 5.1 percent to $3.29 in pre-market trading. Merrimack declared a $1.06 special dividend. BioTime, Inc. (NYSE: BTX) shares rose 4.8 percent to $3.50 in pre-market trading. BioTime, reported the formation of new subsidiary AgeX Therapeutics, Inc. Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) shares rose 4.8 percent to $12.26 in pre-market trading after gaining 0.69 percent on Wednesday. Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 3.6 percent to $39.15 in pre-market trading after the company posted better-than
- [By Ben Levisohn]
Jazz Pharmaceuticals (JAZZ) has jumped 6.3% to $149.45 after settling a patent dispute.
CarMax (KMX) gained 2.4% to $58 after beating earnings and sales forecasts.
Top 5 Heal Care Stocks To Invest In Right Now: Twitter, Inc.(TWTR)
- [By Chris Lange]
Twitter Inc. (NYSE: TWTR) second-quarter results are scheduled for Thursday. The consensus forecast is $0.05 in EPS on $535.61 million in revenue. Shares were last seen at $20.11. The consensus price target is $15.09. The 52-week trading range is $14.12 to $25.25.
- [By Daniel Sparks]
Shares are down about 10% on Thursday after Twitter’s (NYSE:TWTR) as investors digest the company’s slowing revenue and user growth reported in its fourth quarter. But there were a few bright spots in the company’s earnings release as well. Here’s an overview of Twitter’s fourth-quarter performance.
- [By Virendra Singh Chauhan]
All the social media platforms including Twitter (NYSE:TWTR), Facebook, Messenger, Instagram, Snapchat, Youtube are essentially fighting for a greater share of users time. As the popular adage goes, “Time is Money” and even more so in the world of online advertising. A greater share of user time is also perceived as higher engagement, which can attract even more ad dollars. Based on a recent report from socialmediatoday.com, Youtube occupies the top spot in terms of time spent on social media platforms, at 40 minutes per day. While Facebook comes in second overall, in combination with Instagram, Facebook’s photo-sharing app, the Menlo Park-based social networking giant accounts for 50 mins of daily usage, making up a 43% share of the average daily time spent on the various social media platforms. Snapchat accounts for just over 20% share, with 25 minutes of daily usage. Facebook with its increasingly popular photo-sharing app, Instagram, still trump their nearest competitors in terms of engagement. In addition, the rising engagement levels on Instagram should only help to increase this lead while also hurting SnapChat, given the huge overlap between the SnapChat and Instagram products.
- [By Lisa Levin]
Twitter Inc (NYSE: TWTR) reported better-than-expected results for its third quarter.
Twitter earned 10 cents per share in the third quarter on revenue of $590 million. Wall Street analysts were expecting the social media company to earn seven cents per share on revenue of $568 million.
Top 5 Heal Care Stocks To Invest In Right Now: Pilot Gold Inc (PLGTF)
- [By SEEKINGALPHA.COM]
Wesdome Gold (OTC:WDOFF) is confirming the potential of its Kiena Deeps discovery with the latest batch of drill results from this venue. Itinerant Musings subscribers who joined us in this trade will be pleased. Treasury Metals (OTC:TSRMF) needs to find more underground ore to justify a construction decision of its Goliath gold project, and it’s doing just that as reported in the latest news release and explained in this article. NuLegacy Gold (OTCQX:NULGF) finally announced results from the twin hole of the Avocado discovery. A detailed discussion will be forthcoming for Itinerant Musings subscribers shortly. Pilot Gold (OTCPK:PLGTF) is making progress at its Goldstrike project in Utah. The latest set of results confirmed the Peg Leg and Covington targets as valid targets for further drilling. Arizona Mining (OTC:WLDVF) is countering controversy by releasing more drill results, and reporting the discovery of Taylor Deeps. The roller coaster continues.
Top 5 Heal Care Stocks To Invest In Right Now: Coca-Cola Bottling Co. Consolidated(COKE)
- [By Douglas A. McIntyre]
Coca-Cola Bottling Co. (NYSE: COKE) had a revenue increase to $2.3 billion in its most recentfiscal year, from $1.7 billion in the previous one. It is moving into Ohio, Indiana, Kentucky, Illinois and West Virginia, which almost certainly will require capital. Its net sales rose 37% in the most recent quarter to $840 million. Management stated this was because of “Organic growth in the legacy territories as well as territory expansion through the acquisition of several new distribution territories from Coca-Cola led to the solid performance.” The current dividend is $1, or 0.66%.